805 related articles for article (PubMed ID: 20167603)
21. Protein phosphatase PPM1B inhibits DYRK1A kinase through dephosphorylation of pS258 and reduces toxic tau aggregation.
Lee YH; Im E; Hyun M; Park J; Chung KC
J Biol Chem; 2021; 296():100245. PubMed ID: 33380426
[TBL] [Abstract][Full Text] [Related]
22. DYRK1A in neurodegeneration and cancer: Molecular basis and clinical implications.
Abbassi R; Johns TG; Kassiou M; Munoz L
Pharmacol Ther; 2015 Jul; 151():87-98. PubMed ID: 25795597
[TBL] [Abstract][Full Text] [Related]
23. DBC1 phosphorylation by ATM/ATR inhibits SIRT1 deacetylase in response to DNA damage.
Zannini L; Buscemi G; Kim JE; Fontanella E; Delia D
J Mol Cell Biol; 2012 Oct; 4(5):294-303. PubMed ID: 22735644
[TBL] [Abstract][Full Text] [Related]
24. The Down syndrome candidate dual-specificity tyrosine phosphorylation-regulated kinase 1A phosphorylates the neurodegeneration-related septin 4.
Sitz JH; Baumgärtel K; Hämmerle B; Papadopoulos C; Hekerman P; Tejedor FJ; Becker W; Lutz B
Neuroscience; 2008 Dec; 157(3):596-605. PubMed ID: 18938227
[TBL] [Abstract][Full Text] [Related]
25. Neprilysin Is Suppressed by Dual-Specificity Tyrosine-Phosphorylation Regulated Kinase 1A (DYRK1A) in Down-Syndrome-Derived Fibroblasts.
Kawakubo T; Mori R; Shirotani K; Iwata N; Asai M
Biol Pharm Bull; 2017; 40(3):327-333. PubMed ID: 28250274
[TBL] [Abstract][Full Text] [Related]
26. A novel inhibitor rescues cerebellar defects in a zebrafish model of Down syndrome-associated kinase Dyrk1A overexpression.
Buchberger A; Schepergerdes L; Flaßhoff M; Kunick C; Köster RW
J Biol Chem; 2021 Jul; 297(1):100853. PubMed ID: 34090874
[TBL] [Abstract][Full Text] [Related]
27. Effect of DYRK1A activity inhibition on development of neuronal progenitors isolated from Ts65Dn mice.
Mazur-Kolecka B; Golabek A; Kida E; Rabe A; Hwang YW; Adayev T; Wegiel J; Flory M; Kaczmarski W; Marchi E; Frackowiak J
J Neurosci Res; 2012 May; 90(5):999-1010. PubMed ID: 22252917
[TBL] [Abstract][Full Text] [Related]
28. DYRK1A-mediated hyperphosphorylation of Tau. A functional link between Down syndrome and Alzheimer disease.
Ryoo SR; Jeong HK; Radnaabazar C; Yoo JJ; Cho HJ; Lee HW; Kim IS; Cheon YH; Ahn YS; Chung SH; Song WJ
J Biol Chem; 2007 Nov; 282(48):34850-7. PubMed ID: 17906291
[TBL] [Abstract][Full Text] [Related]
29. DYRK1A autophosphorylation on serine residue 520 modulates its kinase activity via 14-3-3 binding.
Alvarez M; Altafaj X; Aranda S; de la Luna S
Mol Biol Cell; 2007 Apr; 18(4):1167-78. PubMed ID: 17229891
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of DYRK1A inhibits choline acetyltransferase induction by oleic acid in cellular models of Down syndrome.
Hijazi M; Fillat C; Medina JM; Velasco A
Exp Neurol; 2013 Jan; 239():229-34. PubMed ID: 23124096
[TBL] [Abstract][Full Text] [Related]
31. Sequence characteristics, subcellular localization, and substrate specificity of DYRK-related kinases, a novel family of dual specificity protein kinases.
Becker W; Weber Y; Wetzel K; Eirmbter K; Tejedor FJ; Joost HG
J Biol Chem; 1998 Oct; 273(40):25893-902. PubMed ID: 9748265
[TBL] [Abstract][Full Text] [Related]
32. Function and regulation of Dyrk1A: towards understanding Down syndrome.
Park J; Song WJ; Chung KC
Cell Mol Life Sci; 2009 Oct; 66(20):3235-40. PubMed ID: 19685005
[TBL] [Abstract][Full Text] [Related]
33. Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity.
Kim EJ; Kho JH; Kang MR; Um SJ
Mol Cell; 2007 Oct; 28(2):277-90. PubMed ID: 17964266
[TBL] [Abstract][Full Text] [Related]
34. Nucleolar protein NOC4L inhibits tumorigenesis and progression by attenuating SIRT1-mediated p53 deacetylation.
Jia X; Liu H; Ren X; Li P; Song R; Li X; Guo Y; Li X
Oncogene; 2022 Sep; 41(39):4474-4484. PubMed ID: 36030331
[TBL] [Abstract][Full Text] [Related]
35. A high-performance liquid chromatography assay for Dyrk1a, a Down syndrome-associated kinase.
Bui LC; Tabouy L; Busi F; Dupret JM; Janel N; Planque C; Delabar JM; Rodrigues-Lima F; Dairou J
Anal Biochem; 2014 Mar; 449():172-8. PubMed ID: 24374000
[TBL] [Abstract][Full Text] [Related]
36. Form of dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 1A nonphosphorylated at tyrosine 145 and 147 is enriched in the nuclei of astroglial cells, adult hippocampal progenitors, and some cholinergic axon terminals.
Kida E; Walus M; Jarząbek K; Palminiello S; Albertini G; Rabe A; Hwang YW; Golabek AA
Neuroscience; 2011 Nov; 195():112-27. PubMed ID: 21878370
[TBL] [Abstract][Full Text] [Related]
37. Truncated Dyrk1A aggravates neuronal apoptosis by inhibiting ASF-mediated Bcl-x exon 2b inclusion.
Zhang S; Zhong J; Xu L; Wu Y; Xu J; Shi J; Gu Z; Li X; Jin N
CNS Neurosci Ther; 2024 Apr; 30(4):e14493. PubMed ID: 37864462
[TBL] [Abstract][Full Text] [Related]
38. The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between beta-amyloid production and tau phosphorylation in Alzheimer disease.
Kimura R; Kamino K; Yamamoto M; Nuripa A; Kida T; Kazui H; Hashimoto R; Tanaka T; Kudo T; Yamagata H; Tabara Y; Miki T; Akatsu H; Kosaka K; Funakoshi E; Nishitomi K; Sakaguchi G; Kato A; Hattori H; Uema T; Takeda M
Hum Mol Genet; 2007 Jan; 16(1):15-23. PubMed ID: 17135279
[TBL] [Abstract][Full Text] [Related]
39. CK2 is the regulator of SIRT1 substrate-binding affinity, deacetylase activity and cellular response to DNA-damage.
Kang H; Jung JW; Kim MK; Chung JH
PLoS One; 2009 Aug; 4(8):e6611. PubMed ID: 19680552
[TBL] [Abstract][Full Text] [Related]
40. Role of Sirtuin1-p53 regulatory axis in aging, cancer and cellular reprogramming.
Ong ALC; Ramasamy TS
Ageing Res Rev; 2018 May; 43():64-80. PubMed ID: 29476819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
